Allergy Immunotherapy Market Size to Surpass USD 3.20 Billion in 2030, exhibiting a CAGR of 9.5%
19 juin 2023 08h00 HE
|
Fortune Business Insights
Pune, India, June 19, 2023 (GLOBE NEWSWIRE) -- The global allergy immunotherapy market size was valued at USD 1.58 billion in 2022. The market is anticipated to grow from USD 1.70 billion in 2023 to...
Sami Nallamshetty, MD, FACAAI Uses Immunotherapy as a Powerful Tool to Treat Asthma and Allergies
19 mai 2023 12h37 HE
|
Florida Medical Clinic
TAMPA. Fla., May 19, 2023 (GLOBE NEWSWIRE) -- “People might know that immunotherapy can fight allergies, but it can help asthma sufferers too,” says Dr. Nallamshetty, who specializes in pediatric...
HpVac reports positive effects of its lead compound HpVac-R13 in a murine model of allergic asthma following oral administration
27 mars 2023 04h00 HE
|
AKAMPION
- Study results indicate beneficial effects on airway hyperresponsiveness, remodeling and inflammation Geneva, Switzerland, March 27, 2023 – HpVac SA, a company developing novel preventive and...
HpVac Appoints Joana Vitte, MD, PhD, as Chief Scientific Officer
23 nov. 2022 04h00 HE
|
AKAMPION
- Significant expansion of allergy research expertise Geneva, Switzerland, November 23, 2022 – HpVac SA, a company developing novel preventive and therapeutic first-line therapies against...
Global Allergy Immunotherapy Market Size to grow USD 4.5 Billion by 2030 | CAGR of 9.5%; Spherical Insights & Consulting
24 oct. 2022 05h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States, Oct. 24, 2022 (GLOBE NEWSWIRE) -- According to a research report published by Spherical Insights & Consulting, the Global Allergy Immunotherapy Market Size to grow from...
HpVac Announces New Animal Data of its Lead Compound Demonstrating Protection Against Allergic Asthma
18 oct. 2022 04h00 HE
|
AKAMPION
- Major milestone for accelerating the development of HpVac-13 in allergic diseases Geneva, Switzerland, October 18, 2022 – HpVac SA, a company developing novel preventive and therapeutic...
Conjunctivitis Market to Grow at a Healthy CAGR of 5.8% from 2022 to 2032 Owing to Growing Disease Prevalence Globally | Future Market Insights, Inc.
26 août 2022 08h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Aug. 26, 2022 (GLOBE NEWSWIRE) -- The global conjunctivitis market is anticipated to portray a phenomenal growth opportunity by exhibiting a 5.8% CAGR with a valuation of US$ 1825.8...
Recent Peer-Reviewed Publication Confirms Patient Satisfaction with Multiple Allergy Immunotherapy Options
17 nov. 2021 09h30 HE
|
Allovate, LLC
New York, Nov. 17, 2021 (GLOBE NEWSWIRE) -- A recent article in the peer-reviewed journal International Forum of Allergy and Rhinology reported the results of a survey offered to individuals with...
Allovate Therapeutics Extends Free Allerdent® Program
23 juil. 2020 15h37 HE
|
Allovate, LLC
New York, July 23, 2020 (GLOBE NEWSWIRE) -- Allovate Therapeutics, a New York-based biotechnology company, announced today that it has extended its free Allerdent® program. Allerdent® is a...
Allovate Therapeutics Provides Free Allerdent® To Physicians
06 mai 2020 09h05 HE
|
Allovate, LLC
New York, May 06, 2020 (GLOBE NEWSWIRE) -- Allovate Therapeutics, a New York-based biotechnology company, announced today that it is making its allergy immunotherapy delivery platform available...